National Health Partners, Inc. (OTC:NHPR)
These days the uninsured pay back more for care-and acquire less-than those with insurance. But when the uninsured can not pay, health care providers adjust those costs to people who can pay-those who have insurance coverage. Which leads to higher prices for those who buy his or her insurance on the personal market, as well as personnel who get insurance policies for themselves and their families through their job. The need for affordable healthcare alternatives has never been greater.
National Health Partners, Inc., a leading provider of unique discount healthcare membership programs, recently announced that NHPR has achieved positive earnings for the quarter ended September 30, 2010 compared to a loss of $522,542 for the same period last year. Revenues for the 3rd quarter grew 12.3% over the same period last year. NHPR attributes the net earnings to the significant cost-cutting initiatives taken over the past couple of quarters and which is continuing in the 4th quarter.
“I am thrilled to announce that we have finally achieved profitability,” stated David M. Daniels, President and Chief Executive Officer of NHPR. “Due to the fact that our limited medical provider unexpectedly decided to exit the marketplace, we were unable to add any new CARExpress Plus limited medical sales during the 3rd quarter. Yet, despite this temporary setback, we were still able to substantially increase our revenue and reach profitability which is a testament to the underlying strength we have with our core CARExpress health discount programs. Although we achieved positive results in revenues and earnings, we anticipate much better results going forward into 2011.”
Mr. Daniels further states “We are seeing continuous growth during the current 4th quarter which should provide strong momentum for the 1st quarter of 2011. Our future has never looked brighter and I am quite confident that we will be able to see accelerating growth in both revenues and earnings. With our continued focus on keeping our operating costs down while at the same time building our revenues at an accelerating rate, we are in a very good position to see very strong earnings growth going forward. I will be providing more information on new business ventures in the very near term that will change the entire complexion of the company and I look forward to continuing to build on the success that we have already started achieving in the 3rd quarter.”
To learn more about NHPR visit: http://www.nationalhealthpartners.com
Oculus Innovative Sciences, Inc. (NASDAQ:OCLS)
Oculus Innovative Sciences, Inc. develops, manufactures, and markets tissue care products based on Microcyn platform technology to treat infections and enhance healing while reducing the need for antibiotics. Its Microcyn platform technology, a solution of electrically charged oxychlorine small molecules, treats various organisms that cause disease or pathogens, including viruses, fungi, spores, and antibiotic-resistant strains of bacteria, such as methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus in wounds, as well as Clostridium difficile. The company offers Microcyn-based products primarily through its Website, and various regional distributors principally in the United States, Europe, and Mexico. It sells its products to hospitals, physicians, and nurses; and other healthcare practitioners, who are the caregivers to patients being treated for acute or chronic wounds, as well as those patients undergoing surgical procedures. The company was formerly known as Micromed Laboratories, Inc. and changed its name to Oculus Innovative Sciences, Inc. in August 2001. Oculus Innovative Sciences was incorporated in 1999 and is based in Petaluma, California.
Oculus Innovative Sciences, Inc. announced today it had received a new FDA 510(k) clearance for its uniquely formulated Microcyn-based Epicyn HydroGel. Under the supervision of a healthcare professional, it is indicated to manage and relieve the burning, itching and pain experienced with various types of dermatoses, including atopic dermatitis and radiation dermatitis. Epicyn HydroGel may also be used to relieve the pain of first- and second-degree burns and can help to relieve dry waxy skin by maintaining a moist wound and skin environment, which is beneficial to the healing process. The hydrogel is a shelf-stable hypochlorous acid formulation based on the company’s proprietary Microcyn Technology platform.
“Our newly approved dermatology indication opens two interesting new markets to Oculus — atopic dermatitis, which afflicts 15 million U.S. patients, and radiation dermatitis, with over one million U.S. patients. The use of the proprietary Microcyn Technology for these challenging skin afflictions is truly a unique approach and adds both depth and breadth to Oculus’ dermatology product portfolio,” said Hoji Alimi, founder and CEO of Oculus. “And in line with our business strategy, we plan to partner this new indication at the earliest for faster commercialization.”
Suntech Power Holdings Co. Ltd. (NYSE:STP) announced that they have been selected by Sempra Generation to design and construct the Mesquite Solar 1 project in Arizona. The renewable electricity generated at Mesquite Solar 1 will be sold to Pacific Gas & Electric under a 150 MW (NYSE:AC), 20-year power purchase agreement pending California Public Utilities Commission approval. Construction on Mesquite Solar 1 is slated to begin in mid-2011, with completion by 2013. The solar facility will create more than 200 local jobs for construction and installation.
Suntech Power Holdings Co., Ltd., a solar energy company, engages in the design, development, manufacture, and marketing of photovoltaic (PV) products. The company also provides engineering, procurement, and construction services to building solar power systems for certain related party and third party customers.
PMI Group Inc. (NYSE:PMI) will host a conference call to review fourth quarter and full year 2010 financial results on Tuesday, February 15, 2011 at 9:00 a.m. PST (12:00 p.m. EST). Financial results for the fourth quarter and full year of 2010 will be released at approximately 3:00 a.m. PST (6:00 a.m. EST) on February 15, 2011.
The PMI Group, Inc., through its subsidiaries, provides residential mortgage insurance products that offer loss protection to mortgage lenders and investors in the event of borrower default in the United States.*****
General Steel Holdings, Inc. (NYSE:GSI) one of China’s leading non-state-owned producers of steel products and aggregators of domestic steel companies, announced that it will test run two newly constructed 1,280 cubic meter blast furnaces, two 120 metric ton converters and one 400 square meter sintering machine at its Longmen Joint Venture. General Steel will have the opportunity to sell and collect revenue from the crude steel produced during the test run of the new equipment. At their designed efficiency levels, the new equipment has the potential to increase production capacity for the Company by three million metric tons of crude steel per year.
General Steel Holdings, Inc., through its subsidiaries, engages in the manufacture and sale of steel products in the People's Republic of China. It offers hot-rolled carbon and silicon steel sheets primarily for use in the production of small agricultural vehicles and other specialty markets.
Signup for FREE Daily Stock Alerts From CRWEFinance.com/signup
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWEFinance.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWEFinance.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://crwefinance.com/disclaimer) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE) has received 3,000,000 shares of (144) restricted common stock from the company and anticipates receiving 3,000,000 shares of free trading shares from a third party for six months of advertisement services for National Health Partners Inc. (OTC:NHPR).